This On Demand Webinar was recorded live during the Medical Affairs and Scientific Communications Annual Forum. 

Subsequently there may be short periods of time where the sound level may vary for any given presentation.  During these short intervals, you may want to turn up the speaker volume on your computer.

This session was chaired by Donna Wartski and Darryl Zaxhary L'Heureux.

The reimbursement landscape has elevated the importance of health economics and outcomes research (HEOR) within the pharmaceutical industry. Demands from payers, population health decision makers, and payment models that incentivize quality have placed higher demands on the data provided and the importance of market access. In addition to clinical attributes such as safety and efficacy, there is an increased demand for evidence supporting the real world use of a drug, including patient experience, medication adherence, comparative effectiveness, and cost implications. It is essential for medical communicators working on any HEOR-related work to understand the role of that work within the context of the value proposition. Furthermore, field medical colleagues such as medical liaisons and outcomes liaisons play an important role in communicating this information to payers to inform their formulary decisions and quality initiatives.

Session Talks Include:

• Demonstrating Value of Medicines Through Health Economic and Outcomes Evidence - Eleni Samaras Allen
• Communicating the Value of Medicines to Payer Customers - Christopher M. Marrone
• Customer Insight - Richard Montgomery